Onivyde 43 mg/10 mL liposome injection Images
Generic Name: irinotecan liposomal
This medication has been identified as Onivyde 43 mg/10 mL liposome injection. It is supplied by Ipsen Biopharmaceuticals, Inc.
Onivyde is used in the treatment of Pancreatic Cancer and belongs to the drug class miscellaneous antineoplastics. Onivyde 43 mg/10 mL liposome injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Onivyde
- Generic Name
- irinotecan liposomal
- Strength
- 43 mg/10 mL liposome injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ipsen Biopharmaceuticals, Inc.
- National Drug Code (NDC)
- 15054-0043
More about Onivyde (irinotecan liposomal)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- En español
Patient resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.